Cleveland BioLabs (Cleveland BioLabs) Beta : N/A (As of May. 05, 2024)

Cleveland BioLabs Beta Chart

Cleveland BioLabs Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
Beta		Get a 7-Day Free Trial					-0.81	-1.12	1.07	2.05	0.91

Cleveland BioLabs Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Beta	Get a 7-Day Free Trial															2.04	1.45	1.04	0.91	0.78

Competitive Comparison of Cleveland BioLabs's Beta

For the Biotechnology subindustry, Cleveland BioLabs's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleveland BioLabs's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cleveland BioLabs's Beta distribution charts can be found below:

* The bar in red indicates where Cleveland BioLabs's Beta falls into.

Cleveland BioLabs Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Cleveland BioLabs  (NAS:CBLI) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Cleveland BioLabs Beta Related Terms

Thank you for viewing the detailed overview of Cleveland BioLabs's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleveland BioLabs (Cleveland BioLabs) Business Description